Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for Lighthouse Lab Services SARS-CoV-2 PCR Test

NEW YORK — The US Food and Drug Administration last week granted Emergency Use Authorization for Lighthouse Lab Services' CovidNow SARS-CoV-2 Assay.

The RT-PCR-based test is designed to detect SARS-CoV-2 nucleic acid in upper respiratory specimens in both symptomatic and asymptomatic individuals. It may also be used with anterior nasal swab specimens self-collected at home by individuals 18 years of age and older using the CovidNow Collection Kit.

Use of the test is limited to laboratories authorized by Charlotte, North Carolina-based Lighthouse Lab Services and CLIA-certified to perform high-complexity tests.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.